Equities

Biosynex SA

Biosynex SA

Actions
  • Price (EUR)2.79
  • Today's Change-0.06 / -2.11%
  • Shares traded465.00
  • 1 Year change-65.27%
  • Beta--
Data delayed at least 15 minutes, as of Nov 14 2024 07:10 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of EUR
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments2687132
Total Receivables, Net213435
Total Inventory383831
Prepaid expenses------
Other current assets, total5.671.200.92
Total current assets91160199
Property, plant & equipment, net168.745.26
Goodwill, net926146
Intangibles, net40265.89
Long term investments2.935.1413
Note receivable - long term------
Other long term assets--0--
Total assets242260269
LIABILITIES
Accounts payable151519
Accrued expenses9.699.3828
Notes payable/short-term debt0.240.040.20
Current portion long-term debt/capital leases5.946.755.95
Other current liabilities, total208.5814
Total current liabilities514067
Total long term debt604529
Total debt665235
Deferred income tax------
Minority interest(0.17)4.37--
Other liabilities, total6.448.434.69
Total liabilities11798101
SHAREHOLDERS EQUITY
Common stock1.081.031.11
Additional paid-in capital262647
Retained earnings (accumulated deficit)98136119
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total----0
Total equity124163168
Total liabilities & shareholders' equity242260269
Total common shares outstanding101010
Treasury shares - common primary issue0.3200.82
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.